gip/glp-1 receptor agonist drugs Dual agonists: New advances for treating type-2 diabetes Potential Use of GLP-1 and
Description
New analyses involving more than 100,000 patients suggest that users of popular diabetes and weight-loss medications face a lower risk of developing certain cancers and a reduced risk of metastasis.
I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance)
We conducted a systematic review and meta-analysis to assess the efficacy and safety of tirzepatide for type 2 diabetes
Consumers of GLP-1 medications such as Ozempic and Wegovy likely need dietary supplements for proper nutrition
Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss
A balanced microbiome environment can help support pathways involved in energy metabolism and appetite regulation
